Metabolic characteristics of converters to ICA positivity in the diabetes prevention trial-type 1 (DPT-1)

被引：0
|
作者：
Sosenko, Jay M.
Wherrett, Diane
Rafkin-Mervis, Lisa
Palmer, Jerry P.
Skyler, Jay S.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A482 / A482
页数：1
相关论文
共 50 条
  • [21] Long-Term Outcome of Individuals Treated With Oral Insulin Diabetes Prevention Trial-Type 1 (DPT-1) oral insulin trial
    Vehik, Kendra
    Cuthbertson, David
    Ruhlig, Holly
    Schatz, Desmond A.
    Peakman, Mark
    Krischer, Jeffrey P.
    DIABETES CARE, 2011, 34 (07) : 1585 - 1590
  • [22] Diabetic Subjects Diagnosed Through the Diabetes Prevention Trial-Type 1 (DPT-1) Are Often Asymptornatic With Normal A1C at Diabetes Onset
    Triolo, Taylor M.
    Chase, H. Peter
    Barker, Jennifer M.
    DIABETES CARE, 2009, 32 (05) : 769 - 773
  • [23] The DPT-1 Trial: a negative result with lessons for future type 1 diabetes prevention
    Pozzilli, P
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (04) : 257 - 259
  • [24] Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1)
    Butty, Vincent
    Campbell, Christopher
    Mathis, Diane
    Benoist, Christophe
    DIABETES, 2008, 57 (09) : 2348 - 2359
  • [25] The Association of C-Peptide with BMI at the Diagnosis of Type 1 Diabetes (T1D) in Children Participating in the Diabetes Prevention Trial-Type 1 (DPT-1)
    Sosenko, Jay M.
    Evans-Molina, Carmella
    Dimeglio, Linda A.
    Rafkin, Lisa E.
    Liu, Yuk-Fun
    Skyler, Jay S.
    Palmer, Jerry P.
    DIABETES, 2016, 65 : A341 - A341
  • [26] The loss of post-challenge C-peptide in the peri-onset period of type 1 diabetes in the Diabetes Prevention Trial-type 1 (DPT-1)
    Sosenko, Jay
    Palmer, Jerry
    Rafkin-Mervis, Lisa
    Krischer, Jeffrey
    Cuthbertson, David
    Matheson, Della
    Skyler, Jay
    DIABETES, 2008, 57 : A502 - A502
  • [27] Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials
    Sosenko, Jay M.
    Skyler, Jay S.
    Herold, Kevan C.
    Schatz, Desmond A.
    Haller, Michael J.
    Pugliese, Alberto
    Cleves, Mario
    Geyer, Susan
    Rafkin, Lisa E.
    Matheson, Della
    Palmer, Jerry P.
    DIABETES, 2020, 69 (08) : 1827 - 1832
  • [28] Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1
    Sosenko, JM
    Palmer, JP
    Greenbaum, CJ
    Mahon, J
    Cowie, C
    Krischer, JP
    Chase, HP
    White, NH
    Buckingham, B
    Herold, KC
    Cuthbertson, D
    Skyler, JS
    DIABETES CARE, 2006, 29 (03) : 643 - 649
  • [29] THE DIABETES PREVENTION TRIAL-TYPE-1 DIABETES (DPT-1) - IMPLEMENTATION OF SCREENING AND STAGING OF RELATIVES
    不详
    DIABETES, 1995, 44 : A129 - A129
  • [30] Transient Diabetic Range Oral Glucose Tolerance Tests and Their Possible Relation to Insulin Resistance Prior to the Diagnosis of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1(DPT-1)
    Sosenko, Jay M.
    Skyler, Jay S.
    Krischer, Jeffrey P.
    Greenbaum, Carla J.
    Rafkin, Lisa
    Mahon, Jeffrey L.
    Cuthbertson, David
    Palmer, Jerry P.
    DIABETES, 2010, 59 : A499 - A499
12345